![Nicholas M. Dean](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Nicholas M. Dean first degree
Entity | Entity type | Industry | |
---|---|---|---|
Excaliard Pharmaceuticals, Inc.
![]() Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nicholas M. Dean via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alta Partners Management Co. LP
![]() Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
UNILEVER PLC | Household/Personal Care | Corporate Officer/Principal | |
Sanarus Medical, Inc.
![]() Sanarus Medical, Inc. Medical SpecialtiesHealth Technology Part of Sanarus Technologies LLC, Sanarus Medical, Inc. manufactures minimally invasive medical devices. The company is based in Pleasanton, CA. The company was founded in 1999 by Seth A. Stabinsky, Glenn Foy. The CEO is BJ Hardman. Sanarus Medical was acquired by Sanarus Technologies LLC on July 16, 2009. | Medical Specialties | Director/Board Member | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Corthera, Inc.
![]() Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Azelon Pharmaceuticals, Inc.
![]() Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Peplin, Inc.
![]() Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
ANNEXON, INC. | Pharmaceuticals: Major | Chairman | |
FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Thesan Pharmaceuticals, Inc.
![]() Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Smith College
![]() Smith College Other Consumer ServicesConsumer Services Smith College opened in 1875 with 14 students. Today, Smith is among the largest women’s colleges in Northampton, MA, with students from 48 states and 72 countries. The college remains strongly committed to the education of women at the undergraduate level, but Smith admits both men and women as graduate students. | College/University | Director/Board Member | |
University of Wisconsin | College/University | Undergraduate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree | |
Ajinomoto Althea, Inc.
![]() Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Medical Specialties | Comptroller/Controller/Auditor | |
The Medical College of Wisconsin, Inc. | College/University | Doctorate Degree | |
Ares-Serono Group
![]() Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Dermatology Foundation | Corporate Officer/Principal | ||
The Hoover Institution | Director/Board Member | ||
Follica, Inc.
![]() Follica, Inc. Other Consumer ServicesConsumer Services Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA. | Other Consumer Services | Chairman | |
Kansas Association of Defense Counsel | Director/Board Member | ||
KITE PHARMA INC | Biotechnology | Director/Board Member | |
DERMIRA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
International Society of Dermatology | Corporate Officer/Principal | ||
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
UCLA Anderson School of Management | College/University | Masters Business Admin | |
Wiggans Living Trust | Director/Board Member | ||
Lipidio Pharmaceuticals, Inc.
![]() Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Chairman | |
Annexon Biosciences, Inc. | Chairman |
Statistics
International
United States | 48 |
United Kingdom | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 29 |
Consumer Services | 7 |
Commercial Services | 5 |
Finance | 4 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 37 |
Corporate Officer/Principal | 12 |
Independent Dir/Board Member | 11 |
Chairman | 10 |
Director of Finance/CFO | 7 |
Most connected contacts
Insiders | |
---|---|
Thomas Wiggans | 31 |
Farah Champsi | 19 |
Alana McNulty | 13 |
Lincoln Krochmal | 9 |
Shawna Miller | 6 |
- Stock Market
- Insiders
- Nicholas M. Dean
- Company connections